Resolute Advisors LLC Viatris Inc Transaction History

Resolute Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $7,580 - $9,204	-627 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $4,014 - $4,584	303 Added 93.52%	627 $8,000
Q2 2021 Dec 27, 2021	BUY	$12.97 - $16.15 $4,202 - $5,232	324 New	324 $5,000
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $4,202 - $5,232	-324 Closed	0 $0
Q1 2021 Dec 27, 2021	BUY	$13.59 - $18.54 $4,403 - $6,006	324 New	324 $3,000

1,094

966M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.5B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resolute Advisors LLC with notifications on news.